3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Lung Neoplasms
3
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm, Residual
2
NSCLC
2
Leukemia, Myeloid, Chronic-Phase
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Effusion
1
Pleural Diseases
1
Philadelphia Chromosome
1
Neoplasms, Second Primary
1
Neoplasms by Site
1
Lung Diseases
1
Liver Neoplasms
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Gastro Intestinal Stromal Tumor
1
Endometrial Neoplasms
1
Congenital Abnormalities
1
Interventions
Radiotherapy
2
Radiosurgery
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
Drug Therapy
2
sacubitril and valsartan sodium hydrate drug combination
1
icotinib
1
dostarlimab
1
beta Carotene
1
avelumab
1
alpha-Tocopherol
1
Varenicline
1
Tyrosine Kinase Inhibitors
1
Trastuzumab
1
Tobacco Use Cessation Devices
1
Therapeutics
1
Thalidomide
1
Temozolomide
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Semen Analysis
1
Registries
1
Probiotics
1
Patient Reported Outcome Measures
1
Panitumumab
1
Nicotine Chewing Gum
1
Myofascial Release Therapy
1
Megestrol Acetate
1
Isotretinoin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Second Primary
×
Tyrosine Kinase Inhibitors
×
Clear all
NCT04151342
2025-12-03
CARMA-BROS
University Health Network, Toronto
Recruiting
5,500 enrolled